tiprankstipranks
Trending News
More News >
Stayble Therapeutics AB (DE:4K4)
:4K4

Stayble Therapeutics AB (4K4) Price & Analysis

Compare
1 Followers

4K4 Stock Chart & Stats


Financials

4K4 FAQ

What was Stayble Therapeutics AB’s price range in the past 12 months?
Stayble Therapeutics AB lowest stock price was €0.02 and its highest was €0.08 in the past 12 months.
    What is Stayble Therapeutics AB’s market cap?
    Stayble Therapeutics AB’s market cap is €2.76M.
      When is Stayble Therapeutics AB’s upcoming earnings report date?
      Stayble Therapeutics AB’s upcoming earnings report date is Aug 26, 2025 which is in 80 days.
        How were Stayble Therapeutics AB’s earnings last quarter?
        Stayble Therapeutics AB released its earnings results on May 20, 2025. The company reported -€0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.004.
          Is Stayble Therapeutics AB overvalued?
          According to Wall Street analysts Stayble Therapeutics AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Stayble Therapeutics AB pay dividends?
            Stayble Therapeutics AB does not currently pay dividends.
            What is Stayble Therapeutics AB’s EPS estimate?
            Stayble Therapeutics AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Stayble Therapeutics AB have?
            Stayble Therapeutics AB has 64,359,795 shares outstanding.
              What happened to Stayble Therapeutics AB’s price movement after its last earnings report?
              Stayble Therapeutics AB reported an EPS of -€0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Stayble Therapeutics AB?
                Currently, no hedge funds are holding shares in DE:4K4

                Company Description

                Stayble Therapeutics AB

                Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
                Similar Stocks
                Company
                Price & Change
                Follow
                Diagonal Bio AB
                LIDDS AB
                Lipigon Pharmaceuticals AB
                CombiGene AB
                QuiaPEG Pharmaceuticals Holding AB
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis